Novatia and TTI Announce Partnership
June 7, 2001
Novatia, LLC (Novatia) and Taylor Technology, Inc. (TTI) are pleased to announce the formation of a strategic alliance. As a result of the partnership, TTI has assumed an equity stake in Novatia in exchange for instrumentation and laboratory space for the pursuit of joint projects.
Since its founding in 1992, TTI has grown rapidly and is now recognized as the premier laboratory providing bioanalytical services in support of both development and discovery programs for the research pharmaceutical industry. Novatia, founded in 2000, has provided consulting services and custom product development services for pharmaceutical and scientific instrumentation manufacturers. Novatia and TTI will be collaborating on the development of novel products and services, with a focus on the exciting opportunities available in the drug discovery, ADME/Tox, and proteomics arenas.
Mark Hail, President of Novatia, commented on the partnership. ìThis is an exciting opportunity for both companies. For Novatia, this gives us the opportunity to expand our product offerings into the analysis areas. Our company was founded on the principal that we would develop technology that we would actually use ourselves. Performing analyses will help drive the development of these new technologies and will enable us to fullfill our vision of offering total analytical solutions to our customers.î
 
©Copyright 2000-2008 Novatia LLC
Disclaimer and terms of usage
e-mail: info@enovatia.com
|
